Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 127 Breast Neoplasms 127 Ovarian Neoplasms 79 Fallopian Tube Neoplasms 45 Lung Neoplasms 42 Carcinoma, Ovarian Epithelial 30 Uterine Cervical Neoplasms 27 Parkinson Disease 4, Autosomal Dominant Lewy Body 27 Endometrial Neoplasms 25 Triple Negative Breast Neoplasms 23 Neoplasm Metastasis 21 Neoplasms 20 Esophageal Neoplasms 19 Stomach Neoplasms 18 Esophageal Squamous Cell Carcinoma 15 Adenocarcinoma of Lung 13 Carcinoma 12 Brenner Tumor 11 Recurrence 10 Urinary Bladder Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Head and Neck Neoplasms 8 Peritoneal Neoplasms 7 Inflammatory Breast Neoplasms 5 Carcinoma, Squamous Cell 5 Adenocarcinoma, Bronchiolo-Alveolar 5 Adenocarcinoma 5 Melanoma 4 Carcinoma, Ductal, Breast 4 Adenocarcinoma Of Esophagus 4

Interventions

ribociclib 1 Trastuzumab 1 Paclitaxel 1 Letrozole 1 Lapatinib 1 Goserelin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Osteitis Deformans × Paclitaxel × Clear all

NCT00553358 2021-09-21

Neo ALTTO

Novartis

Phase 3 Completed

455 enrolled 34 charts

Breast Neoplasms, Osteitis Deformans

Data powered by HemOnc (CC BY 4.0) Colophon ⚡